What is Rgenta Therapeutics worth?
$119.0Mlast known valuation
Rgenta Therapeutics last raised $8.9M in its Early Stage VC (Nov 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Rgenta Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2021 | Early Stage VC | $8.9M | ▮ | ▮ |
| Jan 2020 | Early Stage VC | $10.0M | ▮ | ▮ |
How Rgenta Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Rgenta Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Rgenta Therapeutics worth?
- Rgenta Therapeutics's last known valuation is $119.0M.
- How much has Rgenta Therapeutics raised?
- Rgenta Therapeutics has raised $98.9M in total funding across 2 recorded rounds.
- When did Rgenta Therapeutics last raise?
- Rgenta Therapeutics last raised in Nov 2021 (Early Stage VC), raising $8.9M.